vTv Therapeutics (VTVT) Tops Q1 EPS by 165c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of $1.65. Revenue for the quarter came in at $36.84 million.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Doncasters (DPC) indicating open around $40, IPO priced at $33
• BlackBerry surges on earnings beat and strong cash flow
• Apple To Skip High-end M6 Mac Chips In Favor Of Ai-focused M7 - Bloomberg